Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-02-13 @ 4:08 PM
Study NCT ID:
NCT00506805
Status:
COMPLETED
Last Update Posted:
2012-05-28
First Post:
2007-07-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies
Sponsor:
Esanex Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
None
Primary Completion Date:
2010-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-24
First Submit QC Date:
None
Study First Post Date:
2007-07-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-05-25
Last Update Post Date:
2012-05-28
Last Update Post Date Type:
ESTIMATED